Research Institute: St Vincent’s Institute of Medical Research
Amount granted: $2 million
Year granted: 2011
This is the third grant which ACRF has made over the years to St Vincent’s Institute of Medical Research institute. Their work includes rational drug design, drug target identification in haematological malignancy, and research into the most common type of bone tumour called osteosarcoma.
This grant enabled the purchase of state-of-the-art equipment to significantly assist with testing and analysis of new treatments for cancer.
Chief Investigator: Professor Michael Parker
What your donations have achieved
Cervical cancer vaccine
We gave initial seed funding to Professor Ian Frazer’s research into the cervical cancer (HPV). Over 150 million doses of vaccine have been delivered worldwide to date.
The pill that melts away cancer
Our long term support of cancer research at WEHI has led to a treatment that melts away certain advanced forms of chronic lymphocytic leukaemia. It has been approved for clinical use in the US, European Union and Australia and is being trialled for other types of cancer.
Personalised cancer diagnosis
In 2015, we awarded $10 million seed funding to an ambitious cancer proteome project that aims to provide each cancer patient a personalised treatment plan within 36 hours. This will improve treatment outcomes and help avoid unnecessary treatments.
Zero childhood cancer
We are one of the founding partners of the initiative that will tackle the most serious cases of infant, childhood and adolescent cancer in Australia. It is a key step towards the program vision of one day helping to cure 100% of children with cancer.